|  News |  Columns |  Reports |  Video Reviews |  Title History |  News Report |
// Carla Howe Shows Off Her Swimsuit Body in Instagram Selfies
// Aubrey O'Day Sticks Out Bikini Butt In New Instagram Pic
// 411's WWE RAW Report 9.15.14
// Joe Rogan May Have Just Called You All a Bunch of Racists
// Acheivement List for WWE 2K15 Leaks


411mania RSS Feeds

Follow 411mania on Twitter!

Add 411 On Facebook

 411mania » MMA » News

Chael Sonnen Fails Another Drug Test
Posted by Dan Plunkett on 06.29.2014

MMAFighting.com reports that in addition to failing a random May 24 drug test for anastrozole and clomiphene, Chael Sonnen failed another unannounced test on from June 5 for HGH, EPO, anastrozole, and hCG. Both random tests were conducted by the Nevada Athletic Commission (NAC) , as Sonnen was scheduled to fight in the state on July 5 against Wanderlei Silva.

Sonnen announced his retirement from MMA on June 11, 2014. In response to the initial failed test, Sonnen claimed he used the banned substances help him recover from years of testosterone replacement therapy, which was recently banned by the NAC, and to help solve fertility issues.

Human growth hormone (HGH) is usually used by athletes to build muscle and gain thus a competitive advantage. Erythropoietin (EPO) is generally used to increase stamina; it was one of the drugs at the center of the Lance Armstrong doping scandal. Human chorionic gonadotropin (hCG), which Sonnen admitted to using after failing the May 24 test, is used to start up testosterone production.

Sonnen's case is slated to be heard at the commission's next meeting on July 23.

Sonnen is currently scheduled to face Andre Galvao in a jiu-jitsu match at Metamoris 4 on August 9.


Top 8 Most Anticipated Fall Shows

Aubrey O'Day Instagrams Booty Pic

Chris Brown - X Review

comments powered by Disqus

Copyright (c) 2011 411mania.com, LLC. All rights reserved.
Click here for our privacy policy. Please help us serve you better, fill out our survey.
Use of this site signifies your agreement to our terms of use.